Literature DB >> 8186372

Induction of inflammatory cytokines in the pleural effusion of cancer patients after the administration of an immunomodulator, OK-432: role of IL-8 for neutrophil infiltration.

I Tsuchiya1, T Kasahara, K Yamashita, Y C Ko, K Kanazawa, K Matsushima, N Mukaida.   

Abstract

When OK-432, a well-known streptococcal preparation for an anti-tumour drug, was administered into the pleural cavity of patients with malignant pleurisy, a rapid and prominent leukocytosis, predominantly consisting of neutrophils, was observed in the cavity. Neutrophil infiltration usually peaked 6-9 h after OK-432 administration, and levelled down after 24 h. Prior to the neutrophil accumulation, transient but marked elevation of various inflammatory cytokine levels including IL-1 beta, TNF-alpha, IL-8 and G-CSF was observed. In particular, IL-8 levels increased more than 10-fold, while GM-CSF did not change significantly. A good correlation between IL-8 levels and neutrophil chemotactic response was observed particularly during 0-3 h. Specific neutralization or removal of IL-8 by antibody column abrogated half of the neutrophil chemotaxis, while neutralization of C5a removed around 40%. Sequential removal of IL-8 and C5a abrogated totally 80% of chemotaxis, confirming that these two factors are mostly responsible for the neutrophil chemotaxis in the pleural fluids. These results have suggested that rapid neutrophil infiltration induced by OK-432 in vivo is ascribable largely to IL-8 and in part to C5a.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8186372     DOI: 10.1016/s1043-4666(05)80010-9

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  2 in total

Review 1.  Thyroglossal duct cysts: anatomy, embryology and treatment.

Authors:  Jackie Chou; Andrew Walters; Robert Hage; Anna Zurada; Maciej Michalak; R Shane Tubbs; Marios Loukas
Journal:  Surg Radiol Anat       Date:  2013-05-21       Impact factor: 1.246

2.  Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432.

Authors:  Yoshihito Morimoto; Hidefumi Takei; Keisei Tachibana; Yoko Nakazato; Ryota Tanaka; Yasushi Nagashima; Kazuhiro Watanabe; Reisuke Seki; Takao Shinohara; Haruhiko Kondo
Journal:  Intern Med       Date:  2018-02-09       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.